title: Cutaneous involvement in Hodgkin's lymphoma: report of two cases.
abstract: Hodgkin's lymphoma (HL) comprises 20 to 30% of all lymphomas. Skin involvement is almost always secondary to visceral or nodal involvement. Secondary cutaneous HL is rare, occurring in only 0.5 to 3.4% of the cases. Herein we report two cases of skin involvement in Hodgkin's disease. One was a 25-year-old female admitted with a draining sinus in the neck. The other was a 19-year-old female admitted with a neck mass and skin papules on her chest and arm. Skin involvement may antecede or can be seen during the course of HL. Better understanding of such cutaneous involvement, which occasionally may be the initial sign of HL, is needed, and a biopsy of any suspicious skin lesion should be considered.
authors.affiliation: Department of Pathology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.
authors.forename: Suna
authors.initials: S
authors.lastname: Erkiliç
authors.forename: Zulal
authors.initials: Z
authors.lastname: Erbagci
authors.forename: N Emrah
authors.initials: NE
authors.lastname: Koçer
authors.forename: Yildirim A
authors.initials: YA
authors.lastname: Bayazit
authors.forename: Celalettin
authors.initials: C
authors.lastname: Camci
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D003937:Diagnosis, Differential; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D012867:Skin / Q000473:pathology*; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000556:secondary; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D015251:Epirubicin; D014747:Vinblastine; D003606:Dacarbazine